Neurodegenerative diseases are those conditions which primarily affect the neurons in the human brain. Neurons are the building blocks of the nervous system which normally don’t reproduce or replace themselves. Damage or disease can lead to such neurodegenerative diseases as Parkinson’s, Alzheimer’s, and Huntington’s disease.
Neurodegenerative Diseases Related News
Tilray gains US Government approval to import a medical cannabis study drug
Import of pharmaceutical grade medical cannabis produced by Tilray® Inc has been approved by the US Drug Enforcement Administration (DEA), with a special study...
Alzheimer’s disease treatment: Amyloid β-protein could be making a comeback
For many years, amyloid β-protein has been a promising therapeutic target, but the study results have been disappointing. New studies have now shown these...
Could osteoporosis be linked to development of dementia?
In almost 60,000 patients, the risk of dementia could be linked to osteoporosis, according to an investigation by the Epidemiology Team of IQVIA, Frankfurt,...
Locked-In Syndrome patients given new revolutionary AI-powered device
Patients with Locked-In Syndrome have been given a new sense of freedom with the first ever wearable continuous communication device.
The EyeControl is a groundbreaking...
How is the EU tackling neurodegenerative diseases?
Health Europa investigates the work of the EU Joint Programme on Neurodegenerative Disease Research, the largest global research initiative aimed at tackling the challenge...
An overview of the Neurotech Investing and Partnering Conference
Health Europa shines a spotlight on the 13th annual Neurotech Investing and Partnering Conference, which took place in Boston, USA, in May.
The 21st Century...
Neurodegenerative disease research funding up by a third since 2011
Global neurodegenerative disease research funding has seen a substantial improvement, with funding being up by a third since 2011, according to a new survey.
As...
Alzheimer’s and herpes virus link has been highlighted in new study
A new commentary by scientists at the universities of Manchester and Edinburgh, UK, on a study by Taiwanese epidemiologists has shown support for the...
Neuroscience Trials Australia – leading the way in clinical trials
Why Australia is undoubtably the place to be for conducting clinical trials in the neuroscience space.
Neuroscience Trials Australia is an Australian-based, niche, not-for-profit contract...
People with traumatic brain injury are at increased risk of dementia
Traumatic brain injury (TBI) is associated with an increased risk of dementia, according to one of the largest studies of its kind.
A nationwide study...
Obstructive sleep apnoea linked with brain changes seen in dementia
Obstructive sleep apnoea (OSA) is associated with changes to the structure of the brain that are also seen in the early stages of dementia,...
New therapy developed to treat lysosomal storage disease
Scientists at the University of Manchester, UK, have developed a new gene therapy that will hopefully be used to treat children with Sanfilippo, a...
WHO release of ICD-11 “important step further for the future of neurology”
The newly released International Statistical Classification of Diseases and Related Health Problems (ICD-11) will be implemented for the World Federation of Neurology, which has...
Dementia risk is now a part of the NHS Health Check
As part of the NHS Health Check programme GP surgeries will soon start speaking to patients about the ways in which they can reduce...
Dementia risk increased in 50-year-olds with higher blood pressure
A new study has found that 50-year-olds with blood pressure higher than normal but still below the threshold commonly used when deciding to treat...
UEA event set to showcase groundbreaking dementia research
Health professionals, carers, people with dementia and members of the public have been invited by academics from the University of East Anglia (UEA), UK,...
How copying movements could help manage Parkinson’s disease
The imitation of movement could be a key tool in the management of Parkinson's disease, new research from psychologists at the University of Manchester,...
Protein ‘off-switch’ in the brain could help find new Alzheimer’s treatments
Understanding that memory, learning and cognitive flexibility depend on a protein ‘off-switch’ in the brain could lead to new treatments for Alzheimer's disease, new...
Is insomnia a long-term side effect of stroke?
Stroke patients experience long-term issues with insomnia, which puts them at an increased risk of depression and limits their ability to learn new skills,...
How depression can negatively affect cognitive function
People with depression or anxiety will have an increased risk of reduced cognitive function due to the advanced speed with which the brain ages,...